Chao Pei-Wen, Chu Hsi, Chen Yung-Tai, Shih Yu-Ning, Kuo Shu-Chen, Li Szu-Yuan, Ou Shuo-Ming, Shih Chia-Jen
1School of Medicine, Taipei Medical University, Taipei, Taiwan. 2Department of Anesthesiology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan. 3School of Medicine, National Yang-Ming University, Taipei, Taiwan. 4Division of Chest, Department of Medicine, Taipei City Hospital, Heping Fuyou Branch, Taipei, Taiwan. 5Division of Nephrology, Department of Medicine, Taipei City Hospital, Heping Fuyou Branch, Taipei, Taiwan. 6National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli County, Taiwan. 7Division of Infectious Diseases, Taipei Veterans General Hospital, Taipei, Taiwan. 8Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan. 9Department of Medicine, Taipei Veterans General Hospital, Yuanshan Branch, Yilan, Taiwan. 10Deran Clinic, Yilan, Taiwan.
Crit Care Med. 2016 Jun;44(6):1067-74. doi: 10.1097/CCM.0000000000001608.
To evaluate the long-term survival rate of critically ill sepsis survivors following cardiopulmonary resuscitation on a national scale.
Retrospective and observational cohort study.
Data were extracted from Taiwan's National Health Insurance Research Database.
A total of 272,897 ICU patients with sepsis were identified during 2000-2010. Patients who survived to hospital discharge were enrolled. Post-discharge survival outcomes of ICU sepsis survivors who received cardiopulmonary resuscitation were compared with those of patients who did not experience cardiopulmonary arrest using propensity score matching with a 1:1 ratio.
None.
Only 7% (n = 3,207) of sepsis patients who received cardiopulmonary resuscitation survived to discharge. The overall 1-, 2-, and 5-year postdischarge survival rates following cardiopulmonary resuscitation were 28%, 23%, and 14%, respectively. Compared with sepsis survivors without cardiopulmonary arrest, sepsis survivors who received cardiopulmonary resuscitation had a greater risk of all-cause mortality after discharge (hazard ratio, 1.38; 95% CI, 1.34-1.46). This difference in mortality risk diminished after 2 years (hazard ratio, 1.11; 95% CI, 0.96-1.28). Multivariable analysis showed that independent risk factors for long-term mortality following cardiopulmonary resuscitation were male sex, older age, receipt of care in a nonmedical center, higher Charlson Comorbidity Index score, chronic kidney disease, cancer, respiratory infection, vasoactive agent use, and receipt of renal replacement therapy during ICU stay.
The long-term outcome was worse in ICU survivors of sepsis who received in-hospital cardiopulmonary resuscitation than in those who did not, but this increased risk of mortality diminished at 2 years after discharge.
在全国范围内评估心肺复苏术后危重症脓毒症幸存者的长期生存率。
回顾性观察队列研究。
数据取自台湾全民健康保险研究数据库。
2000年至2010年期间共识别出272,897例患有脓毒症的重症监护病房(ICU)患者。纳入存活至出院的患者。采用倾向评分1:1匹配的方法,将接受心肺复苏的ICU脓毒症幸存者出院后的生存结局与未经历心脏骤停的患者进行比较。
无。
接受心肺复苏的脓毒症患者中仅有7%(n = 3,207)存活至出院。心肺复苏术后1年、2年和5年的总体出院后生存率分别为28%、23%和14%。与未发生心脏骤停的脓毒症幸存者相比,接受心肺复苏的脓毒症幸存者出院后全因死亡风险更高(风险比,1.38;95%置信区间,1.34 - 1.46)。2年后这种死亡风险差异减小(风险比,1.11;95%置信区间,0.96 - 1.28)。多变量分析显示,心肺复苏术后长期死亡的独立危险因素包括男性、年龄较大、在非医疗中心接受治疗、较高的Charlson合并症指数评分、慢性肾病、癌症(肿瘤)、呼吸道感染、使用血管活性药物以及在ICU住院期间接受肾脏替代治疗。
在医院接受心肺复苏的ICU脓毒症幸存者的长期结局比未接受心肺复苏的患者更差,但这种增加的死亡风险在出院后2年时降低。